Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.

Langlais CS, Cowan JE, Neuhaus J, Kenfield SA, Van Blarigan EL, Broering JM, Cooperberg MR, Carroll P, Chan JM.

Cancer Epidemiol Biomarkers Prev. 2019 Aug 28. doi: 10.1158/1055-9965.EPI-19-0488. [Epub ahead of print]

PMID:
31462398
2.

Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer.

Xu MJ, Kornberg Z, Gadzinski AJ, Diao D, Cowan JE, Wu SY, Boreta L, Spratt DE, Behr SC, Nguyen HG, Cooperberg MR, Davicioni E, Roach M 3rd, Hope TA, Carroll PR, Feng FY.

Eur Urol Oncol. 2019 Jan 14. pii: S2588-9311(18)30194-9. doi: 10.1016/j.euo.2018.11.002. [Epub ahead of print]

PMID:
31411984
3.

Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.

Jeong CW, Cowan JE, Broering JM, Ten Ham RMT, Wilson LS, Carroll PR, Cooperberg MR.

Eur Urol. 2019 Jul 22. pii: S0302-2838(19)30536-6. doi: 10.1016/j.eururo.2019.07.012. [Epub ahead of print]

PMID:
31345635
4.

Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research.

Odisho AY, Bridge M, Webb M, Ameli N, Eapen RS, Stauf F, Cowan JE, Washington SL 3rd, Herlemann A, Carroll PR, Cooperberg MR.

JCO Clin Cancer Inform. 2019 Jul;3:1-8. doi: 10.1200/CCI.18.00084.

5.

Identification of an Intronic Regulatory Element Necessary for Tissue-Specific Expression of Foxn1 in Thymic Epithelial Cells.

Larsen BM, Cowan JE, Wang Y, Tanaka Y, Zhao Y, Voisin B, Constantinides MG, Nagao K, Belkaid Y, Awasthi P, Takahama Y, Bhandoola A.

J Immunol. 2019 Aug 1;203(3):686-695. doi: 10.4049/jimmunol.1801540. Epub 2019 Jun 26.

PMID:
31243087
6.

Effects of Initial Gleason Grade on Outcomes during Active Surveillance for Prostate Cancer.

Masic S, Cowan JE, Washington SL, Nguyen HG, Shinohara K, Cooperberg MR, Carroll PR.

Eur Urol Oncol. 2018 Oct;1(5):386-394. doi: 10.1016/j.euo.2018.04.018. Epub 2018 May 24.

PMID:
31158077
7.

Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor.

Balakrishnan AS, Zhao S, Cowan JE, Broering JM, Cooperberg MR, Carroll PR.

Urology. 2019 Sep;131:157-165. doi: 10.1016/j.urology.2019.05.018. Epub 2019 May 28.

PMID:
31150694
8.

Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.

Zuniga KB, Zhao S, Kenfield SA, Cedars B, Cowan JE, Van Blarigan EL, Broering JM, Carroll PR, Chan JM.

J Urol. 2019 May 15:101097JU0000000000000336. doi: 10.1097/JU.0000000000000336. [Epub ahead of print]

PMID:
31091175
9.

A 17-Gene Genomic Prostate Score as a Predictor of Adverse Pathology for Men on Active Surveillance.

Kornberg Z, Cooperberg MR, Cowan JE, Chan JM, Shinohara K, Simko JP, Tenggara I, Carroll PR.

J Urol. 2019 Apr 26:101097JU0000000000000290. doi: 10.1097/JU.0000000000000290. [Epub ahead of print]

PMID:
31026214
10.

Stability of a 17-Gene Genomic Prostate Score in Serial Testing of Men on Active Surveillance of Early Stage Prostate Cancer.

Cedars BE, Washington SL 3rd, Cowan JE, Leapman M, Tenggara I, Chan JM, Cooperberg MR, Carroll PR.

J Urol. 2019 Apr 8:101097JU0000000000000271. doi: 10.1097/JU.0000000000000271. [Epub ahead of print]

PMID:
30958742
11.

Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance.

Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR.

J Urol. 2019 Sep;202(3):506-510. doi: 10.1097/JU.0000000000000247. Epub 2019 Aug 8.

PMID:
30958738
12.

Correlation of a Commercial Genomic Risk Classifier with Histological Patterns in Prostate Cancer.

Greenland NY, Zhang L, Cowan JE, Carroll PR, Stohr BA, Simko JP.

J Urol. 2019 Jul;202(1):90-95. doi: 10.1097/JU.0000000000000175. Epub 2019 Jun 7.

PMID:
30810466
13.

ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLS.

Lange JM, Gulati R, Leonardson AS, Lin DW, Newcomb LF, Trock BJ, Carter HB, Cooperberg MR, Cowan JE, Klotz LH, Etzioni R.

Ann Appl Stat. 2018 Sep;12(3):1773-1795. doi: 10.1214/17-AOAS1130. Epub 2018 Sep 11.

14.

Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.

Leapman MS, Nguyen HG, Cowan JE, Xue L, Stohr B, Simko J, Cooperberg MR, Carroll PR.

Eur Urol. 2018 Nov;74(5):668-675. doi: 10.1016/j.eururo.2018.08.020. Epub 2018 Sep 1.

PMID:
30181067
15.

Genomic Prostate Score, PI-RADS™ version 2 and Progression in Men with Prostate Cancer on Active Surveillance.

Kornberg Z, Cowan JE, Westphalen AC, Cooperberg MR, Chan JM, Zhao S, Shinohara K, Carroll PR.

J Urol. 2019 Feb;201(2):300-307. doi: 10.1016/j.juro.2018.08.047.

PMID:
30179620
16.

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment.

Schmidt B, Eapen RS, Cowan JE, Broering JM, Greene KL, Carroll PR, Cooperberg MR.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):117-124. doi: 10.1038/s41391-018-0084-3. Epub 2018 Aug 31.

PMID:
30171230
17.

The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer.

Cooperberg MR, Erho N, Chan JM, Feng FY, Fishbane N, Zhao SG, Simko JP, Cowan JE, Lehrer J, Alshalalfa M, Kolisnik T, Chelliserry J, Margrave J, Aranes M, Plessis MD, Buerki C, Tenggara I, Davicioni E, Carroll PR.

Eur Urol. 2018 Oct;74(4):444-452. doi: 10.1016/j.eururo.2018.05.014. Epub 2018 May 28.

18.

Development of a stress response therapy targeting aggressive prostate cancer.

Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, Walter P, Carroll PR, Ruggero D.

Sci Transl Med. 2018 May 2;10(439). pii: eaar2036. doi: 10.1126/scitranslmed.aar2036.

19.

Aire controls the recirculation of murine Foxp3+ regulatory T-cells back to the thymus.

Cowan JE, Baik S, McCarthy NI, Parnell SM, White AJ, Jenkinson WE, Anderson G.

Eur J Immunol. 2018 May;48(5):844-854. doi: 10.1002/eji.201747375. Epub 2018 Jan 29.

20.

Comparative Analysis of Biopsy Upgrading in Four Prostate Cancer Active Surveillance Cohorts.

Inoue LYT, Lin DW, Newcomb LF, Leonardson AS, Ankerst D, Gulati R, Carter HB, Trock BJ, Carroll PR, Cooperberg MR, Cowan JE, Klotz LH, Mamedov A, Penson DF, Etzioni R.

Ann Intern Med. 2018 Jan 2;168(1):1-9. doi: 10.7326/M17-0548. Epub 2017 Nov 28.

21.

Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™).

Tat D, Kenfield SA, Cowan JE, Broering JM, Carroll PR, Van Blarigan EL, Chan JM.

Prostate. 2018 Jan;78(1):32-39. doi: 10.1002/pros.23441. Epub 2017 Nov 6.

22.

Community-based Outcomes of Open versus Robot-assisted Radical Prostatectomy.

Herlemann A, Cowan JE, Carroll PR, Cooperberg MR.

Eur Urol. 2018 Feb;73(2):215-223. doi: 10.1016/j.eururo.2017.04.027. Epub 2017 May 9.

PMID:
28499617
23.

Active Surveillance in Younger Men With Prostate Cancer.

Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR.

J Clin Oncol. 2017 Jun 10;35(17):1898-1904. doi: 10.1200/JCO.2016.68.0058. Epub 2017 Mar 27.

24.

Interpreting Patient Reported Urinary and Sexual Function Outcomes across Multiple Validated Instruments.

Vertosick EA, Vickers AJ, Cowan JE, Broering JM, Carroll PR, Cooperberg MR.

J Urol. 2017 Sep;198(3):671-677. doi: 10.1016/j.juro.2017.03.121. Epub 2017 Mar 22.

25.

Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.

Leapman MS, Cowan JE, Simko J, Roberge G, Stohr BA, Carroll PR, Cooperberg MR.

Eur Urol. 2017 May;71(5):750-759. doi: 10.1016/j.eururo.2016.11.032. Epub 2016 Dec 9.

PMID:
27940155
26.

A Randomized Study of Intraoperative Autologous Retropubic Urethral Sling on Urinary Control after Robotic Assisted Radical Prostatectomy.

Nguyen HG, Punnen S, Cowan JE, Leapman M, Cary C, Welty C, Weinberg V, Cooperberg MR, Meng MV, Greene KL, Garcia M, Carroll PR.

J Urol. 2017 Feb;197(2):369-375. doi: 10.1016/j.juro.2016.08.122. Epub 2016 Sep 28.

PMID:
27693447
27.

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.

Tran GN, Leapman MS, Nguyen HG, Cowan JE, Shinohara K, Westphalen AC, Carroll PR.

Eur Urol. 2017 Aug;72(2):275-281. doi: 10.1016/j.eururo.2016.08.023. Epub 2016 Aug 29.

PMID:
27595378
28.

Serial Anatomical Prostate Ultrasound during Prostate Cancer Active Surveillance.

Eltemamy MM, Leapman MS, Cowan JE, Westphalen A, Shinohara K, Carroll PR.

J Urol. 2016 Sep;196(3):727-33. doi: 10.1016/j.juro.2016.03.179. Epub 2016 Apr 24.

PMID:
27117443
29.

CCR7 Controls Thymus Recirculation, but Not Production and Emigration, of Foxp3(+) T Cells.

Cowan JE, McCarthy NI, Anderson G.

Cell Rep. 2016 Feb 9;14(5):1041-1048. doi: 10.1016/j.celrep.2016.01.003. Epub 2016 Jan 28.

30.

Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development.

McCarthy NI, Cowan JE, Nakamura K, Bacon A, Baik S, White AJ, Parnell SM, Jenkinson EJ, Jenkinson WE, Anderson G.

J Immunol. 2015 Sep 15;195(6):2675-82. doi: 10.4049/jimmunol.1501226. Epub 2015 Aug 7.

31.

Natural Th17 cells are critically regulated by functional medullary thymic microenvironments.

Jenkinson WE, McCarthy NI, Dutton EE, Cowan JE, Parnell SM, White AJ, Anderson G.

J Autoimmun. 2015 Sep;63:13-22. doi: 10.1016/j.jaut.2015.06.008. Epub 2015 Jul 3.

32.

Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer.

Filippou P, Welty CJ, Cowan JE, Perez N, Shinohara K, Carroll PR.

Eur Urol. 2015 Sep;68(3):458-63. doi: 10.1016/j.eururo.2015.06.011. Epub 2015 Jun 29.

PMID:
26138041
33.

Patterns of Local Failure following Radiation Therapy for Prostate Cancer.

Jalloh M, Leapman MS, Cowan JE, Shinohara K, Greene KL, Roach M 3rd, Chang AJ, Chan JM, Simko JP, Carroll PR.

J Urol. 2015 Oct;194(4):977-82. doi: 10.1016/j.juro.2015.04.111. Epub 2015 May 14.

PMID:
25983194
34.

Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.

Hampson LA, Cowan JE, Zhao S, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Sep;68(3):480-6. doi: 10.1016/j.eururo.2015.01.008. Epub 2015 Feb 2.

35.

Current Use of Imaging after Primary Treatment of Prostate Cancer.

Hussein AA, Punnen S, Zhao S, Cowan JE, Leapman M, Tran TC, Washington SL, Truesdale MD, Carroll PR, Cooperberg MR.

J Urol. 2015 Jul;194(1):98-104. doi: 10.1016/j.juro.2015.01.097. Epub 2015 Jan 30.

PMID:
25640648
36.

Untreated Gleason Grade Progression on Serial Biopsies during Prostate Cancer Active Surveillance: Clinical Course and Pathological Outcomes.

Hussein AA, Welty CJ, Ameli N, Cowan JE, Leapman M, Porten SP, Shinohara K, Carroll PR.

J Urol. 2015 Jul;194(1):85-90. doi: 10.1016/j.juro.2015.01.077. Epub 2015 Jan 23.

PMID:
25623742
37.

Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: what we learn from intrathymic migration.

Cowan JE, Jenkinson WE, Anderson G.

Eur J Immunol. 2015 Mar;45(3):652-60. doi: 10.1002/eji.201445108. Epub 2015 Feb 13. Review.

38.

Extended followup and risk factors for disease reclassification in a large active surveillance cohort for localized prostate cancer.

Welty CJ, Cowan JE, Nguyen H, Shinohara K, Perez N, Greene KL, Chan JM, Meng MV, Simko JP, Cooperberg MR, Carroll PR.

J Urol. 2015 Mar;193(3):807-11. doi: 10.1016/j.juro.2014.09.094. Epub 2014 Sep 28.

39.

Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.

Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18.

40.

Differential requirement for CCR4 and CCR7 during the development of innate and adaptive αβT cells in the adult thymus.

Cowan JE, McCarthy NI, Parnell SM, White AJ, Bacon A, Serge A, Irla M, Lane PJ, Jenkinson EJ, Jenkinson WE, Anderson G.

J Immunol. 2014 Aug 1;193(3):1204-12. doi: 10.4049/jimmunol.1400993. Epub 2014 Jul 2.

41.

Autologous retro-pubic urethral sling: a novel, quick, intra-operative technique to improve continence after robotic-assisted radical prostatectomy.

Punnen S, Clint Cary K, Glass AS, Cowan JE, Carroll PR.

J Robot Surg. 2014 Jun;8(2):99-104. doi: 10.1007/s11701-013-0432-1. Epub 2013 Aug 15.

PMID:
27637518
42.

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.

Klein EA, Cooperberg MR, Magi-Galluzzi C, Simko JP, Falzarano SM, Maddala T, Chan JM, Li J, Cowan JE, Tsiatis AC, Cherbavaz DB, Pelham RJ, Tenggara-Hunter I, Baehner FL, Knezevic D, Febbo PG, Shak S, Kattan MW, Lee M, Carroll PR.

Eur Urol. 2014 Sep;66(3):550-60. doi: 10.1016/j.eururo.2014.05.004. Epub 2014 May 16.

43.

Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics.

Jalloh M, Myers F, Cowan JE, Carroll PR, Cooperberg MR.

Eur Urol. 2015 Mar;67(3):451-7. doi: 10.1016/j.eururo.2014.03.026. Epub 2014 Apr 5.

44.

Limited ability of existing nomograms to predict outcomes in men undergoing active surveillance for prostate cancer.

Wang SY, Cowan JE, Cary KC, Chan JM, Carroll PR, Cooperberg MR.

BJU Int. 2014 Dec;114(6b):E18-E24. doi: 10.1111/bju.12554. Epub 2014 Feb 20.

45.

A risk-adjusted definition of biochemical recurrence after radical prostatectomy.

Morgan TM, Meng MV, Cooperberg MR, Cowan JE, Weinberg V, Carroll PR, Lin DW.

Prostate Cancer Prostatic Dis. 2014 Jun;17(2):174-9. doi: 10.1038/pcan.2014.5. Epub 2014 Mar 11.

PMID:
24614692
46.

Age and baseline quality of life at radical prostatectomy--who has the most to lose?

Brajtbord JS, Punnen S, Cowan JE, Welty CJ, Carroll PR.

J Urol. 2014 Aug;192(2):396-401. doi: 10.1016/j.juro.2014.02.045. Epub 2014 Feb 25.

PMID:
24582539
47.

An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells.

White AJ, Jenkinson WE, Cowan JE, Parnell SM, Bacon A, Jones ND, Jenkinson EJ, Anderson G.

J Immunol. 2014 Mar 15;192(6):2659-66. doi: 10.4049/jimmunol.1303057. Epub 2014 Feb 7.

48.

Serial prostate biopsy and risk of lower urinary tract symptoms: results from a large, single-institution active surveillance cohort.

Glass AS, Hilton JF, Cowan JE, Washington SL, Carroll PR.

Urology. 2014 Jan;83(1):33-8. doi: 10.1016/j.urology.2013.05.070. Epub 2013 Nov 15.

PMID:
24246319
49.

Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.

Cary KC, Singla N, Cowan JE, Carroll PR, Cooperberg MR.

J Urol. 2014 Apr;191(4):964-70. doi: 10.1016/j.juro.2013.10.098. Epub 2013 Oct 29.

50.

Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.

Cary KC, Cowan JE, Sanford M, Shinohara K, Perez N, Chan JM, Meng MV, Carroll PR.

Eur Urol. 2014 Aug;66(2):337-42. doi: 10.1016/j.eururo.2013.08.060. Epub 2013 Sep 9.

PMID:
24035632

Supplemental Content

Loading ...
Support Center